CRIS Current Research Information System

SCOTLANDI, KATIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.841
NA - Nord America 4.630
EU - Europa 3.452
AF - Africa 294
SA - Sud America 249
OC - Oceania 10
Totale 13.476
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.558
VN - Vietnam 1.706
SG - Singapore 1.171
CN - Cina 1.040
IT - Italia 888
GB - Regno Unito 628
DE - Germania 515
HK - Hong Kong 336
SE - Svezia 324
FR - Francia 204
IN - India 195
BR - Brasile 176
RU - Federazione Russa 157
NL - Olanda 146
CI - Costa d'Avorio 126
IE - Irlanda 126
CH - Svizzera 106
KR - Corea 106
UA - Ucraina 89
JP - Giappone 68
FI - Finlandia 62
ZA - Sudafrica 57
TG - Togo 55
EE - Estonia 47
CA - Canada 44
BG - Bulgaria 40
AR - Argentina 32
JO - Giordania 32
ID - Indonesia 31
PH - Filippine 23
PL - Polonia 23
TR - Turchia 23
BE - Belgio 21
AT - Austria 18
BD - Bangladesh 18
PK - Pakistan 18
MX - Messico 16
TH - Thailandia 16
ES - Italia 15
SC - Seychelles 15
IQ - Iraq 14
EG - Egitto 12
CL - Cile 11
NG - Nigeria 9
AU - Australia 8
EC - Ecuador 7
LT - Lituania 7
MA - Marocco 7
PE - Perù 7
VE - Venezuela 7
GR - Grecia 6
TW - Taiwan 6
IR - Iran 5
SA - Arabia Saudita 5
CO - Colombia 4
DO - Repubblica Dominicana 4
PT - Portogallo 4
UZ - Uzbekistan 4
AL - Albania 3
DK - Danimarca 3
HN - Honduras 3
HR - Croazia 3
MY - Malesia 3
RO - Romania 3
TN - Tunisia 3
AZ - Azerbaigian 2
DZ - Algeria 2
FJ - Figi 2
GE - Georgia 2
HU - Ungheria 2
KE - Kenya 2
KG - Kirghizistan 2
KH - Cambogia 2
LB - Libano 2
LV - Lettonia 2
ME - Montenegro 2
OM - Oman 2
PY - Paraguay 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GT - Guatemala 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MK - Macedonia 1
MZ - Mozambico 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
Totale 13.468
Salva come PNG Salva come JPEG
Città #
Singapore 825
Southend 511
Ashburn 505
Fairfield 441
Chandler 387
Ho Chi Minh City 366
Hanoi 325
Hong Kong 325
Woodbridge 223
Bologna 218
Hefei 211
Dong Ket 210
San Jose 209
Wilmington 206
Ann Arbor 195
Seattle 188
Houston 185
Santa Clara 168
Cambridge 157
Princeton 136
Beijing 135
Frankfurt am Main 131
Abidjan 126
Dublin 126
Boardman 101
Bern 100
Seoul 88
Lauterbourg 78
Los Angeles 69
Dallas 64
Nanjing 60
Tokyo 59
Council Bluffs 57
Lomé 55
New York 52
Helsinki 50
Westminster 49
Berlin 46
Da Nang 46
Jacksonville 46
Haiphong 44
Turin 43
Bremen 42
Padova 42
Milan 40
Sofia 40
Florence 35
Amman 32
Saint Petersburg 31
San Diego 31
Redondo Beach 30
Buffalo 28
Jinan 28
Amsterdam 26
Biên Hòa 26
London 26
Guangzhou 25
Shanghai 24
Falkenstein 23
São Paulo 23
Jakarta 22
Redmond 22
Can Tho 21
Nuremberg 21
Bengaluru 20
Phoenix 20
Shenyang 19
Brussels 18
Changsha 18
Catanzaro 17
Des Moines 17
Hebei 17
San Giovanni in Persiceto 17
Hải Dương 16
Hangzhou 15
Rome 15
Tianjin 15
Warsaw 15
Falls Church 14
Ha Long 14
Paris 14
Mülheim 13
Ninh Bình 13
Dearborn 12
Medford 12
Munich 12
Nanchang 12
Parma 12
Redwood City 12
Chicago 11
Jiaxing 11
Verona 11
Vienna 11
Brooklyn 10
Bắc Giang 10
Lappeenranta 10
Quận Ba 10
Shenzhen 10
Cairo 9
Chennai 9
Totale 8.745
Salva come PNG Salva come JPEG
Nome #
ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity 373
Altered modulation of lamin A/C-HDAC2 interaction and p21 expression during oxidative stress response in HGPS 330
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations 317
Integrated molecular characterization of patient-derived models reveals therapeutic strategies for treating CIC-DUX4 sarcoma 279
Lamin A and prelamin A counteract invasiveness of osteosarcoma cells 269
Combined Treatment with PI3K Inhibitors BYL-719 and CAL-101 Is a Promising Antiproliferative Strategy in Human Rhabdomyosarcoma Cells 255
CD99 contributes to the EWS::FLI1 transcriptome by specifically affecting FOXM1-targets involved in the G2/M cell cycle phase, thus influencing the Ewing sarcoma genetic landscape 236
A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy 224
Molecular mechanisms of CD99-induced caspase-independent cell death and cell-cell adhesion in Ewing's sarcoma cells: actin and zyxin as key intracellular mediators. 219
CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activity. 218
New Insights into the Hepcidin-Ferroportin Axis and Iron Homeostasis in iPSC-Derived Cardiomyocytes from Friedreich's Ataxia Patient 213
Tumoral immune-infiltrate (IF), PD-L1 expression and role of CD8/TIA-1 lymphocytes in localized osteosarcoma patients treated within protocol ISG-OS1 212
CD99 Acts as an Oncosuppressor in Osteosarcoma. 211
CD99 polymorphisms significantly influence the probability to develop Ewing sarcoma in earlier age and patient disease progression 211
IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience 204
Cell growth inhibition and apoptotic effect of the rexinoid 6-OH-11-O-hydroxyphenantrene on human osteosarcoma and mesenchymal stem cells. 204
Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma 203
Insulin-like growth factor 2 mRNA-binding protein 3 is a novel post-transcriptional regulator of Ewing sarcoma malignancy 202
Circulating miR34a levels as a potential biomarker in the follow-up of Ewing sarcoma 201
SELNET clinical practice guidelines for soft tissue sarcoma and GIST 196
An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas. 191
Exosomes from CD99-deprived Ewing sarcoma cells reverse tumor malignancy by inhibiting cell migration and promoting neural differentiation 191
Lamin A and the LINC complex act as potential tumor suppressors in Ewing Sarcoma 191
CD99 drives terminal differentiation of osteosarcoma cells by acting as a spatial regulator of ERK 1/2. 190
A Mutation Threshold Distinguishes the Antitumorigenic Effects of the Mitochondrial Gene MTND1, an Oncojanus Function 190
Targeting CD99 compromises the oncogenic effects of the chimera EWS-FLI1 by inducing re-expression of zyxin and inhibition of Gli1 activity 187
Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors. 184
Biological indicators of prognosis in Ewing’s sarcoma: an emerging role for lectin galactoside-binding soluble 3 binding protein (LGALS3BP). 184
High metastatic efficiency of human sarcoma cells in Rag2/gamma c double knockout mice provides a powerful test system for antimetastatic targeted therapy 184
Bone Turnover Marker (BTM) Changes after Denosumab in Giant Cell Tumors of Bone (GCTB): A Phase II Trial Correlative Study 183
Synovial Sarcoma Preclinical Modeling: Integrating Transgenic Mouse Models and Patient-Derived Models for Translational Research 183
Characterization of human mesenchymal stem cells from Ewing sarcoma patients. Pathogenetic implications 182
Does MGMT (O6-methylguanine–DNA methyltransferase) have a role in metastatic Ewing sarcoma (ES) patients (pts) undergoing temozolomide (TMZ) and irinotecan (IRI)? 179
Abstract 3201: Insulin-like growth factor 2 (IGF-2) mRNA binding protein 3 predicts poor prognosis and promotes cell proliferation in Ewing sarcoma 179
Targeting ROCK2 rather than ROCK1 inhibits Ewing sarcoma malignancy 178
CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity 176
Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling 174
Apoptotic genes as potential markers of metastatic phenotype in human osteosarcoma cell lines. 173
Treatment of nonmetastatic Ewing's sarcoma family tumors of the spine and sacrum: the experience of a single institution 172
Prelamin A-mediated recruitment of SUN1 to the nuclear envelope directs nuclear positioning in human muscle. 172
Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients 171
ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis 170
Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis 167
Lamin A acts a tumor suppressor in Ewing sarcoma promoting neural differentiation and reducing cell migration and invasion 167
Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug. 166
Expression levels of insulin receptor substrate-1 modulate the osteoblastic differentiation of mesenchymal stem cells and osteosarcoma cells. 161
Immune-infiltrate characterization in localized osteosarcoma patients treated within protocol ISG-OS1. 158
Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expression 158
Identification of common and distinctive mechanisms of resistance to different anti-IGF-IR agents in Ewing's sarcoma 157
Low level mutations in the Bcr-Abl kinase domain may already be detected at diagnosis both in patients with Philadelphia-positive acute lymphoblastic leukemia and in patients with chronic phase chronic myeloid leukemia 157
Innovative Breakthroughs for the Treatment of Advanced and Metastatic Synovial Sarcoma 156
NVE-BEZ235 as a new therapeutic option for sarcomas. 155
Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2) 154
Irinotecan and temozolomide upfront and in relapsed Ewing sarcoma: A translational study on MGMT (O6-methylguanine–DNA methyltransferase) and ABCG2 (MGMTLiberati) 154
Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Modulates Aggressiveness of Ewing Sarcoma by Regulating the CD164-CXCR4 Axis 152
Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma 147
Preclinical in vivo study of new insulin-like growth factor-I receptor-specific inhibitor in Ewing’s sarcoma. 146
Osteosarcoma and Ewing Sarcoma of Bone: An Italian Mono-Institutional Epidemiological Study 145
Targeting CD99 in association with doxorubicin: An effective combined treatment for Ewing’s sarcoma 142
Sunitinib Exerts In Vitro Immunomodulatory Activity on Sarcomas via Dendritic Cells and Synergizes With PD-1 Blockade 142
Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types 140
Insulin-like growth factor binding protein 3 as an anti-cancer molecule in Ewing's sarcoma. 139
Polymorphic variants of IGF2BP3 and SENCR have an impact on predisposition and/or progression of Ewing sarcoma 138
Prelamin A is involved in early steps of muscle differentiation. 131
PD1 and PDL1 expression, tumoral microenvironment (TME) characterization and clinical implication in localized osteosarcoma 131
miRNA signature predicts survival of Ewing’s sarcoma patients and miR34a directly influences cell chemosensitivity and malignancy 128
Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells 125
SELNET clinical practice guidelines for bone sarcoma 124
Genomic profiling of a collection of patient-derived xenografts and cell lines identified ixabepilone as an active drug against chemo-resistant osteosarcoma 123
Stromal SPARC contributes to the detrimental fibrotic changes associated with myeloproliferation whereas its deficiency favors myeloid cell expansion. 121
Differentially expressed genes in multidrug resistant variants of U-2 OS human osteosarcoma cells. 120
Zyxin in Ewing sarcoma: a novel role as mediator between CD99 and EWS-FLI1 113
The role of zyxin as a mediator between CD99 and EWS-FLI1 112
Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33 110
Gene amplification is associated with methotrexate resistance in human osteosarcoma cell lines 109
Identification of candidate genes involved in the reversal of malignant phenotype of osteosarcoma cells transfected with the liver/bone/kidney alkaline phosphatase gene 100
Reversal of multidrug-resistance using Valspodar (PSC 833) and doxorubicin in osteosarcoma. 82
Corrigendum to “SELNET clinical practice guidelines for bone sarcoma” Critical reviews in oncology/hematology, vol. 174 (2022), 1–10 (Critical Reviews in Oncology / Hematology (2022) 174, (S1040842822001093), (10.1016/j.critrevonc.2022.103685)) 77
null 70
null 3
Totale 13.741
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.963
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.963
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021578 0 0 0 0 0 0 0 0 0 58 48 472
2021/20221.429 93 42 85 82 115 71 47 103 66 151 313 261
2022/20231.827 151 216 91 254 110 124 74 96 302 58 186 165
2023/2024500 35 93 45 58 35 85 35 32 18 25 12 27
2024/20251.909 106 246 149 143 272 104 101 84 28 168 111 397
2025/20264.810 626 625 413 405 515 220 529 199 957 321 0 0
Totale 13.741